chrisvoncsefalvay/vaers-outcomes huggingface dataset:
5cm x 3cm erythematous indurated circular area. Left upper lateral arm. Patient reports myalgias and subjective fevers the next 2 days after injection.
fever; This spontaneous case was reported by a non-health professional and describes the occurrence of PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Headache, Myalgia, Fever, NauseaVomiting, h/a body aches nausea low grade fever Narrative:
Headache, NauseaVomiting, "feeling whoozy" Narrative:
vomiting, diarrhea, screaming, lethargy, lack of appetite, fever
cold sweaty palm dyspnea and unable to breath, weak pulse + RR > 60/m HR hard to detect because of so weak. given Epinephrine  1x1000 (a 3ml a kd) shot in one min and call 911 and transfer ER of Hospital.
Within 18 hours of administration, my arm started hurting and I lost some range of motion. This continued for 2 weeks, so I went to the doctor.
09/20/04: Mom says that she put ice on immunization the PM of vaccine 09/07/04.  She did not notice any excessive swelling until date of doctor's appointment on 09/09/04.  MD appointment was to actually see about rash. MD hospitalized with knees. The pt is a 4 year old male who presents for direct admission from office secondary to extremely swollen, red, feverish, right leg status post vaccinations at the health department two days ago. Mom reports she had not noticed this was this swollen until this morning. The child has complained that his leg hurt since he got his vaccines two days ago and has been "limping around the house".  Mother did not note any fever or chills and in fact, actually brought him in for complaint of rash on his face and in the left groin area. She reports that she did not actually notice his swelling of his leg until he got to the office today.
experience some mild numbing of the pinky on the arm that received the shot; This is a spontaneous report from a contactable consumer reported for a patient. A male patient unspecified age received an unspecified dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown, Expiry date: unknown) via an unspecified route of administration, in arm on an unknown date at a single dose for covid-19 immunisation. Patient medical history and concomitant medication were not reported. The patient had not known allergies. On 20Jan2021, the patient experienced some mild numbing of the pinky on the arm that received the shot. The facility where the most recent COVID-19 vaccine was administered was Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Post the vaccination, the patient has not been tested for COVID-19. It was unknown whether treatment was received for the adverse event. The outcome of the event was recovering.  Information on the lot/batch number has been requested.  Follow-up (19Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Pain in left arm at site of injection and down left side.  Painful to move or raise arm.  Pain persists for four days with no indication of lessening.
On 11/04/2022 I received my Covid-19 vaccine. On 11/25/2022 I started having severs headaches visual issues and sensitivity to light. I am following up with my neurologist.
Child developed fever of 100.3 (per mom) and had grand mal seizure. Paramedics were called in and child was taken to hospital and diagnosed febrile seizure. Temp at hospital ER was 104.5.
Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Nausea-Mild, Systemic: Visual Changes/Disturbances-Mild, Systemic: Vomiting-Mild, Additional Details: Patient started feeling dizzy within 5 minutes after vaccine administration. Patient vomitted once during observation period. Patient also stated feeling ringing in ears and vision darkening right before throwing up. Patient felt better after throwing up. Patient was observed for total 30 minutes.
Patient woke on 1/12 with violent shaking, nausea, fatigue and decreased appetite. Throughout the day on 1/12 pt became delirious, no longer recognizing people, not able to understand speech, incontinence of bladder and is unable to walk without falling.
I put the vaccines in our EMR (billing system). I noted the vaccine (MMR) was expired; no further AEs reported; expired dose of MMR II; This spontaneous report has been received from a nurse referring to a 4-year-old male patient. The patient's pertinent medical history, drug reactions or allergies were not reported. The patient's concomitant vaccines included: second dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) and the fifth dose of diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, polio vaccine inact 3v (vero), tetanus vaccine toxoid (KINRIX).  On 13-MAY-2021, the patient was vaccinated during routine school vaccination with the second dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant human albumin (rha) (M-M-R II) 1 subcutaneous injection for prophylaxis (formulation, concentration, anatomical site of vaccination were not reported; lot number S007813 and expiration date 14-MAR-2021, which were verified as valid).   It was noted after the administration of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) that the vaccine had expired (expired product administered), (wrong technique in product usage process). The patient's response was normal, drug treatment was not required, and there were no additional adverse events to report.
Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 05Apr2021 at 10:15 hours (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history were reported as none. The patient did not receive any medication within two weeks of vaccination. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 06:00 hours, the patient experienced diarrhea. The patient did not receive any treatment for the reported event. The adverse event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event diarrhea was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Local swelling, erythema around injection site. Rx BENADRYL, ibuprofen.
Patient received the 6M-11Y vaccine, dose 0.25 mL and he should have received the 12+ dose 0.5 mL. Parent was advised the child should return to his pediatrician and get the correct dose. Pediatrician office was contacted of the error.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 13Sep2022 as dose 6 (booster), single (Batch/Lot number: unknown) at the age of 73 years, in left arm for covid-19 immunisation; bnt162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), in left arm, as dose 2, single (Batch/Lot number: unknown), in left arm, on 19Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm, on 25Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm and in 2022 as dose 5 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing); "obesity" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Sep2023, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. Therapeutic measures (Paxlovid) were taken as a result of drug ineffective, covid-19 from 29Sep2023 to 03Oct2023.  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5, bnt162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300328810 same patient, different drug and event;
I had a fever, aches and fatigue after the vaccine for about 48 hours. I developed arthritis in my feet and hands in 05/2022 and it was diagnosed in 08/2022. It was diagnosed as an autoimmune disease in 02/2023. I am undergoing test to determine what disease I have.
0843 vaccine administered.  0855 patient reported a rapid heart rate (112 beats per minute) and tremors.  No airway complications.
Systemic: Fainting / Unresponsive-Severe, Additional Details: Fainted after vaccine -- but ok and went home no issue
Patient felt flushed, dizziness, 5 minutes after immunization.  Vital signs stable.
(L) pain over scapular region and humerus, numbness/tingling on fingers and toes (L) side about 5 day post vac, continued to worsen and intensified till 11/1 and (L) side of entire body = excruciating pain, unrelenting - 11/2 pain and numbness starts up on (R) side - fingers, toes, numb, tingling and (L) eye twitching, tearing and tingling, numbness down to top of cheekbone.
DIFFICULTY BREATHING, FAST HEARTBEAT, DIZZINESS, WEAKNESS, HEARTBEAT GOT PROGRESSIVELY FASTER ALONG WITH THE DIFFICULTY TO BREATHE, BECAME WEAKER. WENT TO EMERGENCY ROOM WHERE I WAS TREATED AND SEEN BY A PHYSICIAN.
left arm was sore; sick; felt off; fatigue; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 69-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st November 2019, the patient received the 1st dose of Shingrix. On 2nd November 2019, 1 days after receiving Shingrix, the patient experienced pain in arm, sickness, feeling abnormal and fatigue. On an unknown date, the outcome of the pain in arm, sickness, feeling abnormal and fatigue were recovered/resolved.   It was unknown if the reporter considered the pain in arm, sickness, feeling abnormal and fatigue to be related to Shingrix.  Additional details were reported as follows: This case was reported by patient for himself. The patient received Shingrix on left arm. Next day after receiving Shingrix, the patient's left arm was sore from the injection and he felt sick, felt off and fatigue which lasted for a few days. The reporter did not consent to follow-up.
This spontaneous report as received from a healthcare worker/pharmacy intern refers to a patient of unknown age. Recently(actual date unspecified) the patient was vaccinated with a dose of ZOSTAVAX (0.65 ml, subcutaneous). On 01-AUG-2014 (reported as within the last ten days) the patient experienced shingles. The patient was screened for contraindications and the reporter states, "they would not have vaccinated if there were any concerns." The patient had contact pharmacy medical attention. The outcome of shingles was unknown. The causality was not reported. Additional information has been requested.
The pt did not have an adverse reaction to either vaccine on 11/17/1999. The pt most likely had a URI - viral infection independent of immunization.
Pt has chickenpox, fever of 99F and a few red spots were first noticed on the pt 6/1/01. A fever on 102F and a rash on face, torso, arms and legs developed that evening. Pt was seen by Dr on 6/2/01 when 75-100 lesions of all stages from macules to vesicles to scabs scattered pt's trunk and extremities. The eventual 300-500 lesion also involved his head, lips, ears, hands, fingertips, palm,soles, of his feet and genital area. Pt was prescribed Zovirax 200mg,2 tsp QID for 4 days. All lesions were dried by 6/8/01. There was no known exposure although another student at his school reported chickenpox at the same time. The pt rec'd varicella vaccine 1/16/97. He was reported to have no measurable antibody on 11/17/97 and rec'd Varivax on 12/23/97.
Upper left arm got itchy and a rash appeared, covering most of upper left arm.  Low grade headache all day, feeling lethargic
1.25 inch diameter red, raised, not painful rash at injection site appeared 6 days post adminstration. No reaction prior to now except a little itching on day of administration.
Low grade fever, shivers, feeling crappy on day one and two. Day 3, 4, and 5 feeling better, but swollen lymph nodes. Today, day 6, low grade fever is back, and lymph nodes are really swollen and painful
Extreme chills lasting for hours followed by severe sweating; entire event lasted 10 hours.
Patient developed burning sensation to face.  MD was contacted by home RN.  She was given Tylenol and Zovirax ointment. Today, 6/9/14 she has the same symptoms.
The site of the injection was red, swollen and painful to touch the next day, 3/31. It became very itchy by Thursday, 4/1. Symptoms subsided by 4/5.
10:10 Patient complaining of some chest tightness. Patient had already used inhaler before medical staff arrived. After arrival, patient stating that felt like she was having trouble breathing, tightness moving up into throat, hoarse, coughing, flushed, rash noted and itchy. At 10:15 am, ambulance called, Epi-injector administered in right upper thigh area. At 10:17 am, Benadryl 50mg 1 cc given in right deltoid. Ambulance arrived at 10:20 am. Sent to E/R in ambulance.
No adverse affects. Pt was given the FLUMIST H1N1 and should have gotten  the shot instead.
Copious loose stools 4/4 to 4/7 present likely Rotavirus GE, not dehydrated.
Headache; Low grade fever; Nausea; Depression; Weak; No appetite; Cough; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3183) via an unspecified route of administration in the left arm on 24Aug2021 at 09:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously took ranitidine hydrochloride (ZANTAC) and morphine sulfate (MORPHINE) and experienced drug allergy. On 25Aug2021 at 07:00, the patient experienced headache, low grade fever, nausea, depression, weak, no appetite and cough. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. On 27Aug2021, the patient underwent nasal swab test for COVID-19 and the result was positive. On 10Sep2021, the patient underwent nasal swab test for COVID-19 and the result was negative. The clinical outcome of the events headache, low grade fever, nausea, depression, weak, no appetite and cough was resolved with sequelae (reported as patient recovered with lasting effects) on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
None. Patient received his second dose one day early. My employer said I had to submit a VAERS.
Severe body aches. Started in my legs 12 hours after the shot. By 2:30 pm  the next day I was very achy. Calmed down by 8:30 pm.
Information has been received from a physician concerning an adult patient who on 17-OCT-2005 was vaccinated intramuscularly with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot 649695/0512P).  On 17-OCT-2005 the patient developed an injection site reaction including redness and swelling , and the area was itchy.  Unspecified medical attention was sought.  Outcome was reported as recovering.  No product quality complaint was involved.  Additional information has been requested.
Completely bedridden Unable to move my arms and legs  Effects lasted 2 days and after 2 days, gradually normal limited (weakened) use of limbs returned
Information has been received from a pharmacist referring to a female patient of unknown age. Information about patient's current condition or medical history was not reported. "2 years ago", in April 2013 the patient got her first dose of VARIVAX (Merck) (lot#, dose, route not reported). Concomitant medications were not provided. The pharmacist reported that the patient was found to fail to seroconvert on an unknown date and the patient was getting another dose of VARIVAX (Merck) (0.5ml subcutaneous, left arm) "today", on 07-APR-2015. Outcome of "fail to seroconvert" was not reported. The causality was not provided. Additional information is not expected as the reporter did not want to be contacted.
An expired Covid-19 pfizer vaccine was administered to the patient on 4/28/22.  The vaccine expired on 4/18/22 at 10am.  The error was discovered on 4/29/22. On 5/3, a COVID-19 Vaccine temperature related enquiry form was filled out and emailed to Pfizer.  On 5-9-22 at 7:51am, we received an email from Pfizer's quality team stating they do not have stability data to support our excursion from prescribed storage conditions. We have reached out to our affected patients informing them of the situation and offered to revaccinate them if they choose to. Left messages on 5-9,5-10 and 5-11 for patient to return our call.
Swollen lymph nodes about 12 hours after taking shot.  Day one only a little swollen. Day two I could not lift my left arm very high without pain.   Large  red area (looks like a rash), below injection point.  A little sensitive when rubbed,  Rash occurred about 36 hours after  injection.
Vagal reaction. Fully recovered after laying flat and drinking water. Monitored for 30 minutes after reaction
PT received Pfizer Covid 19 vaccine 7 days prior to scheduled 2nd dose date. No treatment and no adverse reactions were reported at the time. First does of Pfizer Covid 19 vaccine was received 3/9/21 with no reported adverse reactions.
Having tooth pain; sore inside the shoulder joint itself on the left 2 to 3 days; This spontaneous case was reported by a consumer and describes the occurrence of TOOTHACHE (Having tooth pain) and VACCINATION SITE JOINT PAIN (sore inside the shoulder joint itself on the left 2 to 3 days) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053E21A, 039A21A and 008C21A) for COVID-19 vaccination.     Concurrent medical conditions included HIV infection.   On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In September 2021, the patient experienced VACCINATION SITE JOINT PAIN (sore inside the shoulder joint itself on the left 2 to 3 days). On an unknown date, the patient experienced TOOTHACHE (Having tooth pain). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Tooth pain, at an unspecified dose and frequency. In September 2021, VACCINATION SITE JOINT PAIN (sore inside the shoulder joint itself on the left 2 to 3 days) had resolved. At the time of the report, TOOTHACHE (Having tooth pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, X-ray: normal (normal) x-ray was normal.         Patient used HIV antiviral medications.  With the 3rd dose of the vaccine he received the flu and meningitis vaccines simultaneously. He was a little sore inside of the shoulder joint itself on the left for 2-3 days after receiving that dose that resolved without additional treatments. He did not take any additional medications or treatments for that arm.  Patient used 5% lidocaine patch for his right shoulder.   This case was linked to MOD-2021-368949, MOD-2021-368910 (Patient Link).
On 2/3/16 after vaccination on 2/1/16 employee reports rash/blistered area at and around injection site, red, itching "a lot", slightly warm to touch. She is afebrile and says she feels fine. Recommended OC itch cream for cpox. Sent home to isolate from others until blisters are dried and scabbed. Symptoms all resolved 2-12-16.
first dose of Moderna COVID 19 vaccine on 13May2021 and she is having her 2nd shot tomorrow (9Jul2021); This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (first dose of Moderna COVID 19 vaccine on 13May2021 and she is having her 2nd shot tomorrow (9Jul2021)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (first dose of Moderna COVID 19 vaccine on 13May2021 and she is having her 2nd shot tomorrow (9Jul2021)). At the time of the report, PRODUCT DOSE OMISSION ISSUE (first dose of Moderna COVID 19 vaccine on 13May2021 and she is having her 2nd shot tomorrow (9Jul2021)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Treatment information was  not provided.
I got hives at the base of my neck, down one side of my rib cage and behind my ears.
no additional AEs; TE case/PROQUAD was administered to 1 patient; This spontaneous report was received from a nurse referring to a 5-year-old female patient. The patient's medical histories, concomitant medications, concurrent conditions and drug reaction/allergies were not reported.  On 05-JAN-2023, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant Human albumin (rHA) (PROQUAD) subcutaneous injection, 0.5 milliliter, once, lot #W028564, expiration date: 06-MAR-2024, administered for prophylaxis (strength, route of administration and anatomical site of administration were not provided) which was improperly stored (product storage error). No additional adverse event was reported (no adverse event).